Rank | Gene Set | Z-score |
---|---|---|
1 | negative T cell selection (GO:0043383) | 8.61736956 |
2 | negative thymic T cell selection (GO:0045060) | 8.56634618 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.87120770 |
4 | regulation of isotype switching to IgG isotypes (GO:0048302) | 7.61280539 |
5 | tolerance induction (GO:0002507) | 7.36353014 |
6 | positive thymic T cell selection (GO:0045059) | 7.27933084 |
7 | thymic T cell selection (GO:0045061) | 6.94431076 |
8 | regulation of T cell tolerance induction (GO:0002664) | 6.73484168 |
9 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.59448371 |
10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.47404732 |
11 | positive T cell selection (GO:0043368) | 6.42204641 |
12 | T cell selection (GO:0045058) | 6.29078831 |
13 | cellular response to interleukin-15 (GO:0071350) | 6.21060458 |
14 | response to interleukin-15 (GO:0070672) | 6.14468264 |
15 | regulation of gamma-delta T cell activation (GO:0046643) | 6.04746128 |
16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.87284209 |
17 | leukocyte aggregation (GO:0070486) | 5.83605614 |
18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.73691164 |
19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.73691164 |
20 | * T cell costimulation (GO:0031295) | 5.57028939 |
21 | * lymphocyte costimulation (GO:0031294) | 5.56633991 |
22 | positive regulation of tolerance induction (GO:0002645) | 5.46168938 |
23 | T cell receptor signaling pathway (GO:0050852) | 5.43251343 |
24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.39586385 |
25 | negative regulation of cell killing (GO:0031342) | 5.39586385 |
26 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 5.34482290 |
27 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.05795425 |
28 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.05795425 |
29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.02791537 |
30 | T cell migration (GO:0072678) | 4.93417184 |
31 | interferon-gamma production (GO:0032609) | 4.92180668 |
32 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.85832640 |
33 | regulation of tolerance induction (GO:0002643) | 4.84509980 |
34 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.82318204 |
35 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.73128998 |
36 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.73128998 |
37 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.70927408 |
38 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.65326866 |
39 | activated T cell proliferation (GO:0050798) | 4.60128366 |
40 | positive regulation of isotype switching (GO:0045830) | 4.57455870 |
41 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.53405276 |
42 | regulation of isotype switching (GO:0045191) | 4.47289119 |
43 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.34643875 |
44 | positive regulation of B cell mediated immunity (GO:0002714) | 4.34643875 |
45 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.21935723 |
46 | regulation of regulatory T cell differentiation (GO:0045589) | 4.20289959 |
47 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.20064053 |
48 | cellular response to type I interferon (GO:0071357) | 4.18431183 |
49 | type I interferon signaling pathway (GO:0060337) | 4.18431183 |
50 | immunoglobulin mediated immune response (GO:0016064) | 4.15060853 |
51 | response to type I interferon (GO:0034340) | 4.14994519 |
52 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.12951558 |
53 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.09903363 |
54 | regulation of B cell mediated immunity (GO:0002712) | 4.07421263 |
55 | positive regulation of interleukin-2 production (GO:0032743) | 4.03608550 |
56 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.99607600 |
57 | regulation of immunoglobulin production (GO:0002637) | 3.97302289 |
58 | positive regulation of humoral immune response (GO:0002922) | 3.94860092 |
59 | positive regulation of DNA recombination (GO:0045911) | 3.93231163 |
60 | positive regulation of immunoglobulin production (GO:0002639) | 3.90996838 |
61 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.90619354 |
62 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.89227251 |
63 | positive regulation of cell killing (GO:0031343) | 3.85006348 |
64 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.78926067 |
65 | regulation of response to tumor cell (GO:0002834) | 3.76973901 |
66 | positive regulation of response to tumor cell (GO:0002836) | 3.76973901 |
67 | positive regulation of immune response to tumor cell (GO:0002839) | 3.76973901 |
68 | regulation of immune response to tumor cell (GO:0002837) | 3.76973901 |
69 | detection of bacterium (GO:0016045) | 3.76032516 |
70 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.74850341 |
71 | B cell receptor signaling pathway (GO:0050853) | 3.74396895 |
72 | regulation of cell killing (GO:0031341) | 3.72893430 |
73 | myeloid dendritic cell differentiation (GO:0043011) | 3.70351583 |
74 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.69329113 |
75 | negative regulation of T cell mediated immunity (GO:0002710) | 3.68121584 |
76 | regulation of immunoglobulin secretion (GO:0051023) | 3.65022806 |
77 | T cell differentiation (GO:0030217) | 3.63539782 |
78 | positive regulation of B cell differentiation (GO:0045579) | 3.63352351 |
79 | detection of other organism (GO:0098543) | 3.60035320 |
80 | regulation of chronic inflammatory response (GO:0002676) | 3.58476461 |
81 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.56741166 |
82 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.56741166 |
83 | modulation by symbiont of host immune response (GO:0052553) | 3.56741166 |
84 | positive regulation by symbiont of host defense response (GO:0052509) | 3.56741166 |
85 | modulation by symbiont of host defense response (GO:0052031) | 3.56741166 |
86 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.56741166 |
87 | regulation of response to interferon-gamma (GO:0060330) | 3.56303250 |
88 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.54801350 |
89 | mast cell activation (GO:0045576) | 3.51074992 |
90 | regulation of B cell differentiation (GO:0045577) | 3.50058771 |
91 | T cell activation (GO:0042110) | 3.49723502 |
92 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.49621115 |
93 | myeloid dendritic cell activation (GO:0001773) | 3.47101423 |
94 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.47020365 |
95 | B cell mediated immunity (GO:0019724) | 3.46580135 |
96 | NIK/NF-kappaB signaling (GO:0038061) | 3.46159687 |
97 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.46096563 |
98 | regulation of defense response to virus by virus (GO:0050690) | 3.45361054 |
99 | germinal center formation (GO:0002467) | 3.44948915 |
100 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.44862945 |
101 | alpha-beta T cell differentiation (GO:0046632) | 3.44055259 |
102 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.41204031 |
103 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.37396123 |
104 | sequestering of actin monomers (GO:0042989) | 3.35802783 |
105 | negative regulation of interleukin-12 production (GO:0032695) | 3.35622487 |
106 | alpha-beta T cell activation (GO:0046631) | 3.34703368 |
107 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.33176135 |
108 | regulation of interleukin-2 production (GO:0032663) | 3.31646391 |
109 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.28232805 |
110 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.27515277 |
111 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.27515277 |
112 | T cell differentiation involved in immune response (GO:0002292) | 3.27515277 |
113 | response to muramyl dipeptide (GO:0032495) | 3.26788524 |
114 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.25718821 |
115 | T-helper cell differentiation (GO:0042093) | 3.25718821 |
116 | * positive regulation of T cell activation (GO:0050870) | 3.23713684 |
117 | positive regulation of interleukin-4 production (GO:0032753) | 3.22870671 |
118 | T cell homeostasis (GO:0043029) | 3.21692588 |
119 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.17556800 |
120 | defense response to protozoan (GO:0042832) | 3.10421219 |
121 | regulation of interleukin-4 production (GO:0032673) | 3.09888075 |
122 | T cell proliferation (GO:0042098) | 3.09867020 |
123 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09133007 |
124 | leukocyte cell-cell adhesion (GO:0007159) | 3.08332201 |
125 | regulation of antigen processing and presentation (GO:0002577) | 3.06310576 |
126 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.05816793 |
127 | lymphocyte migration (GO:0072676) | 3.04253143 |
128 | response to protozoan (GO:0001562) | 3.03823325 |
129 | B cell homeostasis (GO:0001782) | 3.01065169 |
130 | response to peptidoglycan (GO:0032494) | 2.99430098 |
131 | macrophage activation involved in immune response (GO:0002281) | 2.97787732 |
132 | cytidine metabolic process (GO:0046087) | 2.96983344 |
133 | cytidine catabolic process (GO:0006216) | 2.96983344 |
134 | cytidine deamination (GO:0009972) | 2.96983344 |
135 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.94420290 |
136 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.91646620 |
137 | positive regulation of antigen processing and presentation (GO:0002579) | 2.91393162 |
138 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.90798551 |
139 | cellular response to interferon-gamma (GO:0071346) | 2.88838614 |
140 | negative regulation of innate immune response (GO:0045824) | 2.86638411 |
141 | regulation of alpha-beta T cell activation (GO:0046634) | 2.85643412 |
142 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.85557639 |
143 | cellular extravasation (GO:0045123) | 2.83685766 |
144 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.83016992 |
145 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.82373767 |
146 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.81400400 |
147 | lymphocyte chemotaxis (GO:0048247) | 2.81271237 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.68570360 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.41563988 |
3 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.07994508 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.00590559 |
5 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.98966867 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.94059080 |
7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.65837008 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.62387297 |
9 | MYB_26560356_Chip-Seq_TH2_Human | 3.42666180 |
10 | MYC_22102868_ChIP-Seq_BL_Human | 3.32883284 |
11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.21922664 |
12 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.20784620 |
13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.99082468 |
14 | MAF_26560356_Chip-Seq_TH1_Human | 2.96980213 |
15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.76139092 |
16 | MYB_26560356_Chip-Seq_TH1_Human | 2.75514623 |
17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.72269513 |
18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.69651396 |
19 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.58849497 |
20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.48189295 |
21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.34164206 |
22 | * MAF_26560356_Chip-Seq_TH2_Human | 2.18989011 |
23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.08624588 |
24 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05088673 |
25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.01528765 |
26 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.00687912 |
27 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.92423628 |
28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.89459205 |
29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.85667903 |
30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81940636 |
31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.78451507 |
32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75241347 |
33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73816638 |
34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66467393 |
35 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64087742 |
36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.62775206 |
37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62224478 |
38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53339289 |
39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.52378328 |
40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52369717 |
41 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51733297 |
42 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.46538489 |
43 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.45084450 |
44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44622170 |
45 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.43702122 |
46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.42816651 |
47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.41332149 |
48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.40858082 |
49 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40222384 |
50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39764576 |
51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38439115 |
52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36502945 |
53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36339873 |
54 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.29537906 |
55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.28264544 |
56 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.26086019 |
57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25725433 |
58 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25541158 |
59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22449119 |
60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19386365 |
61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19056031 |
62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.17906958 |
63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15253668 |
64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11971597 |
65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10704493 |
66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07942232 |
67 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.07801620 |
68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07271809 |
69 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05330090 |
70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04335177 |
71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04079676 |
72 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.02676793 |
73 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.01735472 |
74 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00432750 |
75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00268887 |
76 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99813235 |
77 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98372560 |
78 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96988077 |
79 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.95935266 |
80 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95680975 |
81 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95368470 |
82 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94551363 |
83 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93364129 |
84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92851719 |
85 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.92411230 |
86 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.90434798 |
87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89041652 |
88 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88652978 |
89 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87700168 |
90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87637474 |
91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87352458 |
92 | GATA1_22025678_ChIP-Seq_K562_Human | 0.85713305 |
93 | * SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.84658181 |
94 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84224499 |
95 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83146196 |
96 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.82636527 |
97 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81956844 |
98 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81671800 |
99 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.80482064 |
100 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.79649497 |
101 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.79340293 |
102 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.79081458 |
103 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.79010190 |
104 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78858384 |
105 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.78663779 |
106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77084791 |
107 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.76673734 |
108 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.76659638 |
109 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.75216823 |
110 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.74930728 |
111 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74393540 |
112 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.72158292 |
113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71615040 |
114 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71429519 |
115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71232165 |
116 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.69789513 |
117 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.65795630 |
118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.65589189 |
119 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.64677785 |
120 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.63934679 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 5.76131882 |
2 | * MP0005671_abnormal_response_to | 5.07186218 |
3 | MP0001835_abnormal_antigen_presentation | 3.68970000 |
4 | MP0000685_abnormal_immune_system | 3.61671107 |
5 | MP0009333_abnormal_splenocyte_physiolog | 3.30136696 |
6 | * MP0001800_abnormal_humoral_immune | 3.27593968 |
7 | * MP0005000_abnormal_immune_tolerance | 3.27224470 |
8 | MP0001790_abnormal_immune_system | 3.14824720 |
9 | MP0005387_immune_system_phenotype | 3.14824720 |
10 | MP0002166_altered_tumor_susceptibility | 3.01822440 |
11 | MP0006082_CNS_inflammation | 3.00790877 |
12 | MP0002723_abnormal_immune_serum | 2.97468614 |
13 | MP0003724_increased_susceptibility_to | 2.93993287 |
14 | MP0009785_altered_susceptibility_to | 2.93967966 |
15 | MP0001819_abnormal_immune_cell | 2.92441352 |
16 | * MP0002420_abnormal_adaptive_immunity | 2.92258907 |
17 | MP0001873_stomach_inflammation | 2.84527344 |
18 | * MP0002398_abnormal_bone_marrow | 2.81528015 |
19 | MP0002405_respiratory_system_inflammati | 2.78540225 |
20 | MP0000703_abnormal_thymus_morphology | 2.69200410 |
21 | MP0005025_abnormal_response_to | 2.66378820 |
22 | MP0002452_abnormal_antigen_presenting | 2.66376621 |
23 | MP0003436_decreased_susceptibility_to | 2.61710835 |
24 | MP0003300_gastrointestinal_ulcer | 2.49230715 |
25 | * MP0000716_abnormal_immune_system | 2.48705684 |
26 | MP0002722_abnormal_immune_system | 2.37631784 |
27 | MP0002006_tumorigenesis | 2.37269052 |
28 | MP0003866_abnormal_defecation | 2.29564818 |
29 | MP0010155_abnormal_intestine_physiology | 2.24776142 |
30 | * MP0000689_abnormal_spleen_morphology | 2.20438651 |
31 | MP0004947_skin_inflammation | 2.13768333 |
32 | MP0002148_abnormal_hypersensitivity_rea | 2.04259544 |
33 | * MP0002429_abnormal_blood_cell | 2.00387871 |
34 | MP0004510_myositis | 1.92772937 |
35 | * MP0002933_joint_inflammation | 1.88329038 |
36 | MP0002396_abnormal_hematopoietic_system | 1.86866709 |
37 | MP0001853_heart_inflammation | 1.86098460 |
38 | MP0002419_abnormal_innate_immunity | 1.84240147 |
39 | MP0009840_abnormal_foam_cell | 1.71170547 |
40 | * MP0001845_abnormal_inflammatory_respons | 1.70519727 |
41 | MP0000858_altered_metastatic_potential | 1.60867281 |
42 | MP0003172_abnormal_lysosome_physiology | 1.56422187 |
43 | MP0009278_abnormal_bone_marrow | 1.56051231 |
44 | MP0003303_peritoneal_inflammation | 1.54872478 |
45 | MP0003448_altered_tumor_morphology | 1.40050831 |
46 | MP0005310_abnormal_salivary_gland | 1.34014528 |
47 | MP0001533_abnormal_skeleton_physiology | 1.29754755 |
48 | MP0008469_abnormal_protein_level | 1.28593117 |
49 | MP0000465_gastrointestinal_hemorrhage | 1.27515070 |
50 | MP0005451_abnormal_body_composition | 1.27194749 |
51 | MP0005464_abnormal_platelet_physiology | 1.25786538 |
52 | MP0001851_eye_inflammation | 1.18557434 |
53 | MP0005058_abnormal_lysosome_morphology | 1.16676822 |
54 | MP0004381_abnormal_hair_follicle | 1.15752685 |
55 | MP0002254_reproductive_system_inflammat | 1.09071881 |
56 | MP0000490_abnormal_crypts_of | 1.04056512 |
57 | MP0002019_abnormal_tumor_incidence | 1.03808823 |
58 | MP0000604_amyloidosis | 0.99696925 |
59 | MP0004808_abnormal_hematopoietic_stem | 0.98367390 |
60 | MP0002277_abnormal_respiratory_mucosa | 0.91938089 |
61 | MP0001348_abnormal_lacrimal_gland | 0.88816118 |
62 | MP0008260_abnormal_autophagy | 0.88742467 |
63 | MP0003045_fibrosis | 0.88664311 |
64 | MP0008057_abnormal_DNA_replication | 0.85610579 |
65 | MP0009763_increased_sensitivity_to | 0.85459086 |
66 | MP0002998_abnormal_bone_remodeling | 0.83655775 |
67 | MP0003075_altered_response_to | 0.82479487 |
68 | MP0002132_abnormal_respiratory_system | 0.82111785 |
69 | MP0003191_abnormal_cellular_cholesterol | 0.80652528 |
70 | MP0005023_abnormal_wound_healing | 0.79552682 |
71 | MP0003183_abnormal_peptide_metabolism | 0.79017866 |
72 | MP0009765_abnormal_xenobiotic_induced | 0.78824065 |
73 | MP0005075_abnormal_melanosome_morpholog | 0.78497846 |
74 | MP0010352_gastrointestinal_tract_polyps | 0.75107635 |
75 | MP0002139_abnormal_hepatobiliary_system | 0.72984077 |
76 | MP0009764_decreased_sensitivity_to | 0.69220839 |
77 | MP0002138_abnormal_hepatobiliary_system | 0.69073419 |
78 | MP0000477_abnormal_intestine_morphology | 0.67511471 |
79 | MP0008961_abnormal_basal_metabolism | 0.65501836 |
80 | MP0003795_abnormal_bone_structure | 0.64157680 |
81 | MP0003091_abnormal_cell_migration | 0.62913002 |
82 | MP0001545_abnormal_hematopoietic_system | 0.61753061 |
83 | MP0005397_hematopoietic_system_phenotyp | 0.61753061 |
84 | MP0001881_abnormal_mammary_gland | 0.60302980 |
85 | MP0005076_abnormal_cell_differentiation | 0.59411192 |
86 | MP0003077_abnormal_cell_cycle | 0.59258552 |
87 | MP0001663_abnormal_digestive_system | 0.59013556 |
88 | MP0005166_decreased_susceptibility_to | 0.57439394 |
89 | MP0000609_abnormal_liver_physiology | 0.57349917 |
90 | MP0002009_preneoplasia | 0.57141562 |
91 | MP0003828_pulmonary_edema | 0.56862371 |
92 | MP0008007_abnormal_cellular_replicative | 0.56725087 |
93 | MP0010234_abnormal_vibrissa_follicle | 0.56319354 |
94 | MP0001243_abnormal_dermal_layer | 0.53857405 |
95 | MP0004957_abnormal_blastocyst_morpholog | 0.52407431 |
96 | MP0001727_abnormal_embryo_implantation | 0.51168982 |
97 | MP0002163_abnormal_gland_morphology | 0.49908476 |
98 | MP0000371_diluted_coat_color | 0.48600992 |
99 | MP0008873_increased_physiological_sensi | 0.47573262 |
100 | * MP0002693_abnormal_pancreas_physiology | 0.47427689 |
101 | MP0008874_decreased_physiological_sensi | 0.47400730 |
102 | MP0002877_abnormal_melanocyte_morpholog | 0.47267854 |
103 | MP0001191_abnormal_skin_condition | 0.46435258 |
104 | MP0005381_digestive/alimentary_phenotyp | 0.46132866 |
105 | MP0000343_altered_response_to | 0.45611017 |
106 | MP0009115_abnormal_fat_cell | 0.44242990 |
107 | MP0000313_abnormal_cell_death | 0.43326093 |
108 | MP0001216_abnormal_epidermal_layer | 0.42435059 |
109 | MP0005390_skeleton_phenotype | 0.42220354 |
110 | * MP0002136_abnormal_kidney_physiology | 0.41269812 |
111 | MP0003221_abnormal_cardiomyocyte_apopto | 0.40835424 |
112 | MP0003453_abnormal_keratinocyte_physiol | 0.39499104 |
113 | MP0003656_abnormal_erythrocyte_physiolo | 0.38820010 |
114 | MP0010307_abnormal_tumor_latency | 0.38684303 |
115 | MP0003693_abnormal_embryo_hatching | 0.38634000 |
116 | MP0002822_catalepsy | 0.38503957 |
117 | MP0010094_abnormal_chromosome_stability | 0.38066995 |
118 | * MP0000249_abnormal_blood_vessel | 0.35193046 |
119 | MP0003329_amyloid_beta_deposits | 0.34876631 |
120 | MP0005165_increased_susceptibility_to | 0.34548696 |
121 | * MP0002083_premature_death | 0.34415003 |
122 | MP0008569_lethality_at_weaning | 0.33064230 |
123 | MP0008872_abnormal_physiological_respon | 0.32717661 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 6.92385100 |
2 | Abnormality of T cell number (HP:0011839) | 6.68031670 |
3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.36011501 |
4 | IgM deficiency (HP:0002850) | 6.26232363 |
5 | Recurrent bronchitis (HP:0002837) | 6.22003607 |
6 | Severe combined immunodeficiency (HP:0004430) | 6.09403006 |
7 | Abnormality of B cell number (HP:0010975) | 5.94104630 |
8 | B lymphocytopenia (HP:0010976) | 5.94104630 |
9 | Combined immunodeficiency (HP:0005387) | 5.54566365 |
10 | Abnormality of T cells (HP:0002843) | 5.52937682 |
11 | IgG deficiency (HP:0004315) | 5.31660952 |
12 | Stomatitis (HP:0010280) | 5.24286122 |
13 | Myositis (HP:0100614) | 5.02715437 |
14 | Eczematoid dermatitis (HP:0000976) | 4.91459917 |
15 | Abnormality of macrophages (HP:0004311) | 4.53427468 |
16 | Autoimmune hemolytic anemia (HP:0001890) | 4.35641462 |
17 | Recurrent bacterial skin infections (HP:0005406) | 4.33860814 |
18 | IgA deficiency (HP:0002720) | 4.31582727 |
19 | Recurrent fungal infections (HP:0002841) | 4.20784952 |
20 | Lymphopenia (HP:0001888) | 4.18906585 |
21 | Panhypogammaglobulinemia (HP:0003139) | 4.18679992 |
22 | Increased IgM level (HP:0003496) | 4.17981674 |
23 | Abnormality of T cell physiology (HP:0011840) | 4.17779620 |
24 | Optic neuritis (HP:0100653) | 4.15839109 |
25 | Retrobulbar optic neuritis (HP:0100654) | 4.15839109 |
26 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.01682323 |
27 | Chronic diarrhea (HP:0002028) | 3.93847532 |
28 | Nasal polyposis (HP:0100582) | 3.77509455 |
29 | Joint swelling (HP:0001386) | 3.75726131 |
30 | Chronic otitis media (HP:0000389) | 3.75185942 |
31 | Orchitis (HP:0100796) | 3.73719634 |
32 | Recurrent cutaneous fungal infections (HP:0011370) | 3.65234870 |
33 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.65234870 |
34 | Gastrointestinal infarctions (HP:0005244) | 3.62919240 |
35 | Recurrent sinusitis (HP:0011108) | 3.61499763 |
36 | Increased density of long bones (HP:0006392) | 3.59572348 |
37 | Abnormality of eosinophils (HP:0001879) | 3.55974818 |
38 | Pulmonary infiltrates (HP:0002113) | 3.55655808 |
39 | Vasculitis (HP:0002633) | 3.53283438 |
40 | Bronchitis (HP:0012387) | 3.50197473 |
41 | Pustule (HP:0200039) | 3.44237750 |
42 | Recurrent viral infections (HP:0004429) | 3.41616385 |
43 | Autoimmune thrombocytopenia (HP:0001973) | 3.41202790 |
44 | Gastrointestinal stroma tumor (HP:0100723) | 3.33902119 |
45 | Colitis (HP:0002583) | 3.16758433 |
46 | Hemoptysis (HP:0002105) | 3.15166774 |
47 | Abnormality of the nasal mucosa (HP:0000433) | 3.14767436 |
48 | Leukocytosis (HP:0001974) | 3.13130513 |
49 | Thyroiditis (HP:0100646) | 3.09208234 |
50 | Recurrent otitis media (HP:0000403) | 2.99101274 |
51 | Keratoconjunctivitis sicca (HP:0001097) | 2.94403557 |
52 | Eosinophilia (HP:0001880) | 2.93246669 |
53 | Lymphoma (HP:0002665) | 2.90997162 |
54 | Hypergammaglobulinemia (HP:0010702) | 2.89318181 |
55 | Meningitis (HP:0001287) | 2.87044786 |
56 | Arterial thrombosis (HP:0004420) | 2.86188726 |
57 | Mediastinal lymphadenopathy (HP:0100721) | 2.82706539 |
58 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.79787015 |
59 | Cellulitis (HP:0100658) | 2.74989268 |
60 | Thrombocytosis (HP:0001894) | 2.74669490 |
61 | Urticaria (HP:0001025) | 2.71620222 |
62 | Abnormality of the fingertips (HP:0001211) | 2.71476163 |
63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.67653478 |
64 | Obstructive lung disease (HP:0006536) | 2.67653478 |
65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.64613089 |
66 | Keratoconjunctivitis (HP:0001096) | 2.64298602 |
67 | Hypoplasia of the thymus (HP:0000778) | 2.60365660 |
68 | Persistence of primary teeth (HP:0006335) | 2.59094269 |
69 | Granulocytopenia (HP:0001913) | 2.58760102 |
70 | Gangrene (HP:0100758) | 2.55741322 |
71 | Encephalitis (HP:0002383) | 2.49603945 |
72 | Basal cell carcinoma (HP:0002671) | 2.47085174 |
73 | Recurrent abscess formation (HP:0002722) | 2.46814823 |
74 | Emphysema (HP:0002097) | 2.42179636 |
75 | Abnormality of the prostate (HP:0008775) | 2.39534304 |
76 | Pulmonary embolism (HP:0002204) | 2.37754053 |
77 | Gingivitis (HP:0000230) | 2.34407599 |
78 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.33510986 |
79 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.33510986 |
80 | Abnormality of glycolipid metabolism (HP:0010969) | 2.33510986 |
81 | Anorexia (HP:0002039) | 2.27629767 |
82 | Chest pain (HP:0100749) | 2.27081964 |
83 | Inflammation of the large intestine (HP:0002037) | 2.24414813 |
84 | Recurrent skin infections (HP:0001581) | 2.22342777 |
85 | Systemic lupus erythematosus (HP:0002725) | 2.21878202 |
86 | Arthralgia (HP:0002829) | 2.21022372 |
87 | Gastrointestinal inflammation (HP:0004386) | 2.19800590 |
88 | Ureteral stenosis (HP:0000071) | 2.19138484 |
89 | Osteomyelitis (HP:0002754) | 2.16331074 |
90 | Premature loss of primary teeth (HP:0006323) | 2.15227484 |
91 | Epistaxis (HP:0000421) | 2.14893540 |
92 | Amaurosis fugax (HP:0100576) | 2.10712882 |
93 | Restrictive lung disease (HP:0002091) | 2.08584271 |
94 | Agammaglobulinemia (HP:0004432) | 2.06878740 |
95 | Petechiae (HP:0000967) | 2.06428934 |
96 | Hypochromic anemia (HP:0001931) | 2.06315785 |
97 | Hypertensive crisis (HP:0100735) | 2.02813038 |
98 | Sepsis (HP:0100806) | 2.01722474 |
99 | Abnormality of the pleura (HP:0002103) | 2.01626486 |
100 | Prolonged bleeding time (HP:0003010) | 2.00681463 |
101 | Bronchiectasis (HP:0002110) | 2.00399452 |
102 | Pulmonary fibrosis (HP:0002206) | 1.99088941 |
103 | Amyotrophic lateral sclerosis (HP:0007354) | 1.98159661 |
104 | Increased cerebral lipofuscin (HP:0011813) | 1.97459916 |
105 | Papilloma (HP:0012740) | 1.97429972 |
106 | Verrucae (HP:0200043) | 1.97429972 |
107 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.97079554 |
108 | Ureteral obstruction (HP:0006000) | 1.96342000 |
109 | Acute hepatic failure (HP:0006554) | 1.95863896 |
110 | Increased serum ferritin (HP:0003281) | 1.94200222 |
111 | Slow saccadic eye movements (HP:0000514) | 1.92932782 |
112 | Polyneuropathy (HP:0001271) | 1.92311177 |
113 | Increased IgE level (HP:0003212) | 1.89821214 |
114 | Interstitial pulmonary disease (HP:0006530) | 1.86587545 |
115 | Chronic sinusitis (HP:0011109) | 1.86562257 |
116 | Abnormality of binocular vision (HP:0011514) | 1.84872923 |
117 | Diplopia (HP:0000651) | 1.84872923 |
118 | Abnormality of the endocardium (HP:0004306) | 1.81947206 |
119 | Acrocyanosis (HP:0001063) | 1.79916077 |
120 | Spontaneous hematomas (HP:0007420) | 1.79313200 |
121 | Skin ulcer (HP:0200042) | 1.78209944 |
122 | Glomerulopathy (HP:0100820) | 1.77689903 |
123 | Skin rash (HP:0000988) | 1.71171178 |
124 | Trigonocephaly (HP:0000243) | 1.70928114 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 7.09680570 |
2 | MAP4K1 | 5.88293569 |
3 | ZAP70 | 4.12330952 |
4 | PRPF4B | 3.63365984 |
5 | RIPK4 | 3.32004932 |
6 | ITK | 3.29899002 |
7 | FGFR4 | 3.20640364 |
8 | JAK3 | 3.19029815 |
9 | KDR | 2.65454107 |
10 | IKBKE | 2.53325011 |
11 | BLK | 2.50605468 |
12 | TYK2 | 2.35188385 |
13 | MAP3K14 | 2.34839753 |
14 | JAK1 | 2.25215560 |
15 | LCK | 2.17178436 |
16 | TBK1 | 2.00217541 |
17 | TESK2 | 1.96111292 |
18 | CSK | 1.87599462 |
19 | FGFR3 | 1.78804007 |
20 | STK10 | 1.76151513 |
21 | SYK | 1.72167465 |
22 | GRK6 | 1.68622267 |
23 | TEC | 1.67634796 |
24 | NLK | 1.52492792 |
25 | HCK | 1.42455302 |
26 | SMG1 | 1.37271234 |
27 | TAOK2 | 1.36422535 |
28 | BTK | 1.20854666 |
29 | NME2 | 1.18495320 |
30 | EEF2K | 1.14620246 |
31 | PRKCH | 1.14310455 |
32 | IKBKB | 1.13588602 |
33 | MAP3K12 | 1.10696166 |
34 | PRKCQ | 1.08834151 |
35 | EPHA3 | 1.07899071 |
36 | KIT | 1.06904865 |
37 | MST4 | 1.03348161 |
38 | BMPR2 | 1.01906646 |
39 | TAOK3 | 1.00169524 |
40 | IRAK4 | 0.96334512 |
41 | LYN | 0.95716790 |
42 | LRRK2 | 0.94025944 |
43 | FGFR1 | 0.89998298 |
44 | GRK7 | 0.87201928 |
45 | CHUK | 0.85761207 |
46 | EPHB1 | 0.84445268 |
47 | FES | 0.83807323 |
48 | MAP3K1 | 0.81289946 |
49 | FGR | 0.79918327 |
50 | MAP3K3 | 0.77639057 |
51 | TYRO3 | 0.74707055 |
52 | MATK | 0.72498321 |
53 | TRIB3 | 0.71634181 |
54 | MAP2K6 | 0.68936144 |
55 | IRAK1 | 0.68572560 |
56 | JAK2 | 0.67945055 |
57 | MAP3K10 | 0.67300784 |
58 | CLK1 | 0.66592909 |
59 | CDC42BPA | 0.66110790 |
60 | MAPK12 | 0.65640024 |
61 | TSSK6 | 0.64711024 |
62 | FYN | 0.62418797 |
63 | IRAK3 | 0.62044309 |
64 | MAPK7 | 0.61741228 |
65 | BRD4 | 0.60465027 |
66 | RPS6KA4 | 0.58915728 |
67 | ALK | 0.58563542 |
68 | SIK2 | 0.58394901 |
69 | PIM1 | 0.57836738 |
70 | INSR | 0.57285382 |
71 | PDGFRB | 0.57280830 |
72 | MAP3K7 | 0.56297514 |
73 | TNK2 | 0.55029342 |
74 | CAMKK1 | 0.54867527 |
75 | SIK3 | 0.53533598 |
76 | MAP3K13 | 0.52432543 |
77 | CSF1R | 0.52080087 |
78 | EIF2AK1 | 0.51880237 |
79 | IGF1R | 0.51133464 |
80 | SIK1 | 0.50097736 |
81 | TGFBR2 | 0.47809858 |
82 | TESK1 | 0.45630528 |
83 | TAOK1 | 0.44767567 |
84 | MAP3K11 | 0.43491517 |
85 | CDC7 | 0.42225846 |
86 | MARK3 | 0.40938330 |
87 | ILK | 0.40698377 |
88 | MAP3K5 | 0.40496831 |
89 | CAMKK2 | 0.40433131 |
90 | PDK1 | 0.40357093 |
91 | CDK4 | 0.40173395 |
92 | TGFBR1 | 0.36866617 |
93 | RPS6KL1 | 0.35298019 |
94 | RPS6KC1 | 0.35298019 |
95 | CDK9 | 0.34785193 |
96 | PRKD2 | 0.33791633 |
97 | CDK12 | 0.32833365 |
98 | NTRK2 | 0.31354606 |
99 | MAPK4 | 0.31291694 |
100 | KSR2 | 0.30612325 |
101 | FGFR2 | 0.30402467 |
102 | PDPK1 | 0.30401139 |
103 | PASK | 0.28593977 |
104 | BUB1 | 0.28406337 |
105 | RPS6KA6 | 0.27131336 |
106 | TLK1 | 0.24953017 |
107 | MAPK11 | 0.24370694 |
108 | HIPK2 | 0.23984075 |
109 | CSNK1A1L | 0.23753238 |
110 | MAPK3 | 0.22270747 |
111 | RPS6KA5 | 0.20760920 |
112 | MELK | 0.19406694 |
113 | ERN1 | 0.19180585 |
114 | PIM2 | 0.18743200 |
115 | EGFR | 0.17543176 |
116 | MAP3K8 | 0.17478327 |
117 | MAPKAPK2 | 0.17097803 |
118 | IRAK2 | 0.16898575 |
119 | MAP2K3 | 0.16707643 |
120 | ACVR1B | 0.16575884 |
121 | SRC | 0.16283482 |
122 | CDK6 | 0.16116947 |
123 | ABL1 | 0.15934085 |
124 | MARK2 | 0.14557026 |
125 | STK24 | 0.14369974 |
126 | PRKCD | 0.13815212 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.49856788 |
2 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.13268865 |
3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.81576304 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.72299324 |
5 | Allograft rejection_Homo sapiens_hsa05330 | 3.67592731 |
6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.18241654 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.17261500 |
8 | Measles_Homo sapiens_hsa05162 | 2.91467185 |
9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.70061327 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.65050161 |
11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.64177637 |
12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.48565292 |
13 | Viral myocarditis_Homo sapiens_hsa05416 | 2.01982747 |
14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.78971982 |
15 | Asthma_Homo sapiens_hsa05310 | 1.77942081 |
16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.76026492 |
17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.74777229 |
18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.74263572 |
19 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.64419827 |
20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.54730971 |
21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43095855 |
22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.40887705 |
23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35091110 |
24 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.30795353 |
25 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.27497405 |
26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26755274 |
27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.21754521 |
28 | Proteasome_Homo sapiens_hsa03050 | 1.19348975 |
29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16973439 |
30 | Shigellosis_Homo sapiens_hsa05131 | 1.13704861 |
31 | HTLV-I infection_Homo sapiens_hsa05166 | 1.13045659 |
32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10233033 |
33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06398641 |
34 | Hepatitis B_Homo sapiens_hsa05161 | 1.01735472 |
35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01125835 |
36 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98721254 |
37 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96884794 |
38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94906278 |
39 | Apoptosis_Homo sapiens_hsa04210 | 0.92122786 |
40 | Malaria_Homo sapiens_hsa05144 | 0.91950431 |
41 | Influenza A_Homo sapiens_hsa05164 | 0.88065229 |
42 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84005439 |
43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82165390 |
44 | Ribosome_Homo sapiens_hsa03010 | 0.80951647 |
45 | Legionellosis_Homo sapiens_hsa05134 | 0.79461445 |
46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77690038 |
47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77233065 |
48 | Spliceosome_Homo sapiens_hsa03040 | 0.76992790 |
49 | Salmonella infection_Homo sapiens_hsa05132 | 0.72539439 |
50 | Phagosome_Homo sapiens_hsa04145 | 0.72111466 |
51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70760361 |
52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68844459 |
53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68383558 |
54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67015973 |
55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66610577 |
56 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.65646596 |
57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65407889 |
58 | Tuberculosis_Homo sapiens_hsa05152 | 0.65295990 |
59 | Lysosome_Homo sapiens_hsa04142 | 0.64998705 |
60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64069154 |
61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.62824408 |
62 | Hepatitis C_Homo sapiens_hsa05160 | 0.61435598 |
63 | DNA replication_Homo sapiens_hsa03030 | 0.61054037 |
64 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54309399 |
65 | Mismatch repair_Homo sapiens_hsa03430 | 0.52561546 |
66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52446990 |
67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51120929 |
68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50958748 |
69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46349357 |
70 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45027331 |
71 | Prion diseases_Homo sapiens_hsa05020 | 0.44071592 |
72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43948972 |
73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43184687 |
74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42011903 |
75 | Platelet activation_Homo sapiens_hsa04611 | 0.40113881 |
76 | Pertussis_Homo sapiens_hsa05133 | 0.40062471 |
77 | Base excision repair_Homo sapiens_hsa03410 | 0.39854801 |
78 | RNA degradation_Homo sapiens_hsa03018 | 0.38194150 |
79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36209056 |
80 | Endocytosis_Homo sapiens_hsa04144 | 0.35337254 |
81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33624003 |
82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33069497 |
83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32390523 |
84 | Prostate cancer_Homo sapiens_hsa05215 | 0.31812371 |
85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30615896 |
86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29886185 |
87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29106338 |
88 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27366350 |
89 | Protein export_Homo sapiens_hsa03060 | 0.26985503 |
90 | Homologous recombination_Homo sapiens_hsa03440 | 0.26844910 |
91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.26687017 |
92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26274884 |
93 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.25833301 |
94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24408522 |
95 | Bladder cancer_Homo sapiens_hsa05219 | 0.24354407 |
96 | Alcoholism_Homo sapiens_hsa05034 | 0.22136453 |
97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.21494770 |
98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.21486005 |
99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20750120 |
100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.20481480 |
101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18954468 |
102 | RNA transport_Homo sapiens_hsa03013 | 0.18264776 |
103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17910075 |
104 | RNA polymerase_Homo sapiens_hsa03020 | 0.16220648 |
105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.16011367 |
106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.15707001 |
107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.15402580 |
108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.13915833 |
109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.13582874 |
110 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.13440622 |
111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.13137480 |
112 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.12206299 |
113 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.11659270 |
114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.11342719 |
115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.09719813 |
116 | Glioma_Homo sapiens_hsa05214 | 0.07613971 |
117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.07300490 |
118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.06496689 |
119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.05738309 |
120 | Thyroid cancer_Homo sapiens_hsa05216 | 0.05360063 |
121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.04564279 |
122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.04347280 |
123 | Insulin resistance_Homo sapiens_hsa04931 | 0.04336061 |
124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.03632358 |
125 | Adherens junction_Homo sapiens_hsa04520 | 0.02909673 |